“Pancreatic+cancer”的搜索结果，显示 101-110 项，共有 9029 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... Tumor Treatment Fields (TTF) in preventing tumor growth in paitents with recurrent recurrent and/or metastatic pancreatic cancer (met-PC). Combination ...

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... cancer. A Study to Compare of the Glycotest™ HCC ... pancreatic adenocarcinoma with limited low volume ... We will collect tumor biopsy specimens before treatment ...

3. 胃肠病科和肝病科- 临床试验- 妙佑医疗国际

   Claudin18.2 CAR-T (CT041) in Patients With Gastric, Pancreatic Cancer, or Other Specified Digestive Cancers. Rochester, Minn. A Phase 1b/2, open label, multi ...

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... Tumor Treatment Fields (TTF) in preventing tumor growth in paitents with recurrent recurrent and/or metastatic pancreatic cancer (met-PC). A Study to ...

5. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... pancreatic cancer or precancer by analyzing the secretions (fluid) from a pancreatic cyst, pancreas fluid and tissue from a resected pancreatic cyst. Group ...

6. 神经科- 临床试验- 妙佑医疗国际

   ... Pancreatic SPORE, “Optimal Immunotargeting of MUC1 for Advanced Pancreatic Cancer” (Principal Investigator Dr. Gendler). Eligibility Criteria, keep current ...

7. 神经科- 临床试验- 妙佑医疗国际

   ... Pancreatic SPORE, “Optimal Immunotargeting of MUC1 for Advanced Pancreatic Cancer” (Principal Investigator Dr. Gendler). Eligibility Criteria, keep current ...

8. 神经科- 临床试验- 妙佑医疗国际

   ... Pancreatic SPORE, “Optimal Immunotargeting of MUC1 for Advanced Pancreatic Cancer” (Principal Investigator Dr. Gendler). Eligibility Criteria, keep current ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... Pancreatic SPORE, “Optimal Immunotargeting of MUC1 for Advanced Pancreatic Cancer” (Principal Investigator Dr. Gendler). Eligibility Criteria, keep current ...

10. 神经科- 临床试验- 妙佑医疗国际

    ... Pancreatic SPORE, “Optimal Immunotargeting of MUC1 for Advanced Pancreatic Cancer” (Principal Investigator Dr. Gendler). Eligibility Criteria, keep current ...